Hartford Financial Management Inc. Neurocrine Biosciences Inc Transaction History

Hartford Financial Management Inc.

  • $450 Million
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Oct 16, 2020
SELL
$96.16 - $135.15 $961 - $1,351
-10 Closed
0 $0
Q1 2020

May 01, 2020
BUY
$75.11 - $113.76 $751 - $1,137
10 New
10 $1,000
Q4 2019

Jan 28, 2020
SELL
$86.8 - $118.57 $7,378 - $10,078
-85 Closed
0 $0
Q3 2019

Oct 28, 2019
BUY
$83.82 - $101.5 $7,124 - $8,627
85 New
85 $8,000

Others Institutions Holding NBIX

# of Institutions
641
Shares Held
95.3M
Call Options Held
661K
Put Options Held
227K
View Full List

About NEUROCRINE BIOSCIENCES INC

NBIX Quotes by TradingView
  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $11B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Hartford Financial Management Inc. Portfolio

Follow Hartford Financial Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hartford Financial Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hartford Financial Management Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email